杏林製薬(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4569/E00985-
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2024/07/19日証協無担保800株-95.51%0株0%200株-60%
2024/07/19日証協有担保236,166株-79.81%3,000株-76.38%153,559株+141.83%
2024/07/12日証協無担保17,800株+17.8%0株0%500株-54.63%
2024/07/12日証協有担保1,169,592株+136.95%12,699株+149.93%63,500株-60.44%
2024/07/05日証協無担保15,110株+421.03%0株0%1,102株+267.33%
2024/07/05日証協有担保493,598株-36.98%5,081株-74.97%160,500株+61.63%
2024/06/28日証協無担保2,900株-79.58%0株0%300株+50%
2024/06/28日証協有担保783,264株-11.51%20,300株-34.52%99,300株+40.85%
2024/06/21日証協無担保14,200株+212.78%0株0%200株-87.5%
2024/06/21日証協有担保885,177株+142.39%31,000株+532.65%70,500株+74.82%
2024/06/14日証協無担保4,540株0%0株0%1,600株-69.24%
2024/06/14日証協有担保365,194株-74.43%4,900株-69.09%40,328株-82.02%
2024/06/07日証協無担保0株-100%0株0%5,201株-30.65%
2024/06/07日証協有担保1,428,374株-36.54%15,852株+14.55%224,341株+197.14%
2024/05/31日証協無担保800株0%0株0%7,500株+256.46%
2024/05/31日証協有担保2,250,815株-9.84%13,839株+14.37%75,500株-41.83%
2024/05/24日証協無担保0株-100%0株0%2,104株+40.27%
2024/05/24日証協有担保2,496,349株+193.84%12,100株-32.52%129,786株-26.67%
2024/05/17日証協無担保27,500株0%0株0%1,500株+275%
2024/05/17日証協有担保849,554株+83.63%17,932株-36.4%176,990株+7.87%
2024/05/10日証協有担保462,635株-40.41%28,195株+29.33%164,075株+153.2%
2024/05/02日証協無担保0株-100%0株0%400株0%
2024/05/02日証協有担保776,318株+458.3%21,800株+128.27%64,800株+4.85%
2024/04/26日証協無担保15,050株-55.6%0株0%0株-100%
2024/04/26日証協有担保139,050株-83.47%9,550株-43.49%61,800株+124.73%
2024/04/19日証協無担保33,900株+9999.99%0株0%1,200株-50%
2024/04/19日証協有担保841,450株+225.51%16,900株-15.08%27,500株-73.96%
2024/04/12日証協無担保120株0%0株0%2,400株-50.04%
2024/04/12日証協有担保258,500株-76.94%19,900株+4.23%105,600株-59.36%
2024/04/05日証協無担保120株-89.09%0株-100%4,804株-85.1%
2024/04/05日証協有担保1,120,839株+48.56%19,093株-66.78%259,866株-24.45%
2024/03/29日証協無担保1,100株-94.79%17,700株0%32,241株+5264.56%
2024/03/29日証協有担保754,478株+14.8%57,477株+5125.18%343,973株+39.33%
2024/03/22日証協無担保21,100株0%0株0%601株-64.65%
2024/03/22日証協有担保657,223株+42.48%1,100株+5.47%246,878株+79.07%
2024/03/15日証協無担保0株0%0株0%1,700株+183.33%
2024/03/15日証協有担保461,268株-10.58%1,043株-70.25%137,869株+33.02%

※株式分割は考慮していませんのでご注意ください。

Page Top